Garriz-Luis, Alexandra
Rodríguez-Toscano, Elisa
Burdeus-Olavarrieta, Mónica
Arango, Celso
Parellada, Mara
Díaz-Caneja, Covadonga M.
Funding for this research was provided by:
11q España
Intramural Research Promotion Program of the Health Research Institute Gregorio Marañón University Hospital (IiSGM).
Article History
Received: 25 September 2024
Accepted: 21 October 2025
First Online: 19 December 2025
Declarations
:
: The ethics committee of the Hospital General Universitario Gregorio Marañón approved the study. All the participants or a legal representative provided written informed consent prior to participation in the study.
: All authors provide their consent for the publication of the manuscript, including any accompanying images or data contained within the manuscript.
: Dr. Arango has been a consultant to or has received honoraria or grants from Abbot, Acadia, Ambrosetti, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, Takeda and Teva. Dr. Díaz-Caneja has received honoraria from Angelini and Viatris and travel support from Janssen and Angelini. The rest of the authors report no conflicts of interest related to this work.